Delivery Order SPE2DB25D2207-SPE2DB25FQQWC
Award Date
5/7/25
Potential Completion Date
5/8/25
Potential Value
$1.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,555.92, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is a delivery order for the supply of NOVOLOG 100 UNIT/ML VIAL 10ML, a diabetes medication. The contract has an ultimate completion date of April 23, 2025 and is a firm fixed-price, non-set-aside procurement. Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,516.26, is a delivery order for 4,568,120,553 units of NOVOLOG 100 UNIT/ML VIAL 10ML, a diabetes treatment medication. The contract is a firm fixed-price, non-set-aside award with a performance period through May 5, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
This federal contract award, valued at $3,001.86, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of NOVOLOG 100 UNIT/ML VIAL 10ML, a diabetes medication, with a period of performance through April 2025. The contract is a firm-fixed price delivery order and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, valued at $5,190.60, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of NOVOLOG 100 UNIT/ML VIAL 10ML, a diabetes medication, with an ultimate completion date of April 24, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides...
This federal contract award, valued at $1,996.98, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of NOVOLOG 100 UNIT/ML VIAL 10ML. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 17, 2025. This award is not associated with a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distribution company. The $1,157.06 firm-fixed-price delivery order is for the supply of NOVOLOG 100 UNIT/ML VIAL 10ML, a medication used for diabetes management. The contract has an ultimate completion date of October 21, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,149.24 firm fixed-price delivery order is for the supply of NOVOLOG 100 UNIT/ML VIAL 10ML medical products. The contract has an ultimate completion date of February 19, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award, valued at $1,296.60, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of NOVOLOG 100 UNIT/ML VIAL 10ML, a pharmaceutical product, with a performance period ending on May 1, 2025. Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which...
This federal contract award, identified as SPE2DB20D1004|SPE2DB25FNGKP, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,485.12, is a delivery order for the provision of NOVOLOG 100 UNIT/ML VIAL 10ML, a medication used to treat diabetes. The contract is a Firm Fixed Price agreement with no set-aside designation, indicating open competition. Amerisourcebergen Drug...
This federal contract award, valued at $1,300.80, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The delivery order contract is for the supply of NOVOLOG 100 UNIT/ML VIAL 10ML, a medication used to treat diabetes. The contract has a firm fixed price pricing type and an ultimate completion date of October 17, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...